Timothy Niecko

466 total citations
24 papers, 350 citations indexed

About

Timothy Niecko is a scholar working on Surgery, Oncology and Genetics. According to data from OpenAlex, Timothy Niecko has authored 24 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Oncology and 6 papers in Genetics. Recurrent topics in Timothy Niecko's work include Lymphatic System and Diseases (5 papers), Inflammatory Bowel Disease (5 papers) and Diagnosis and Treatment of Venous Diseases (5 papers). Timothy Niecko is often cited by papers focused on Lymphatic System and Diseases (5 papers), Inflammatory Bowel Disease (5 papers) and Diagnosis and Treatment of Venous Diseases (5 papers). Timothy Niecko collaborates with scholars based in United States, United Kingdom and Switzerland. Timothy Niecko's co-authors include Loretto Lacey, Brian G. Feagan, Raymond J. Townsend, David W. Miller, Martin Buxton, Jeffrey D. White, William J. Sandborn, Steven Hass, Christopher R. McBurney and Margaret C. Reilly and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and The Journal of Pediatrics.

In The Last Decade

Timothy Niecko

22 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timothy Niecko United States	11	90	88	82	77	64	24	350
Dorota Walkiewicz Poland	9	37 0.4×	89 1.0×	166 2.0×	126 1.6×	33 0.5×	17	457
Benjamin A. Goldenberg Canada	11	29 0.3×	43 0.5×	85 1.0×	50 0.6×	31 0.5×	23	381
Angelyn Fairchild United States	9	141 1.6×	35 0.4×	78 1.0×	74 1.0×	15 0.2×	20	327
Julie Bolen United States	9	29 0.3×	38 0.4×	41 0.5×	76 1.0×	41 0.6×	10	381
Alice Heaney United Kingdom	10	81 0.9×	72 0.8×	12 0.1×	29 0.4×	41 0.6×	27	317
Sandra Elnegaard Denmark	11	18 0.2×	47 0.5×	12 0.1×	63 0.8×	36 0.6×	16	351
David A. Barondess United States	10	37 0.4×	135 1.5×	48 0.6×	56 0.7×	8 0.1×	15	577
Katie Mellor United Kingdom	12	39 0.4×	93 1.1×	16 0.2×	22 0.3×	16 0.3×	29	327
Rikke Pilsgaard Svendsen Denmark	11	21 0.2×	39 0.4×	13 0.2×	48 0.6×	34 0.5×	13	366
S T Thio Singapore	7	63 0.7×	28 0.3×	11 0.1×	44 0.6×	31 0.5×	10	418

Countries citing papers authored by Timothy Niecko

Since Specialization

Citations

This map shows the geographic impact of Timothy Niecko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Niecko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Niecko more than expected).

Fields of papers citing papers by Timothy Niecko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Niecko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Niecko. The network helps show where Timothy Niecko may publish in the future.

Co-authorship network of co-authors of Timothy Niecko

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Niecko. A scholar is included among the top collaborators of Timothy Niecko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Niecko. Timothy Niecko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ko, Dicken S.C., Emily S. Lukacz, Iver A. Juster, et al.. (2023). Real-World Evidence That a Novel Diagnostic Combining Molecular Testing With Pooled Antibiotic Susceptibility Testing is Associated With Reduced Infection Severity and Lower Cost Compared With Standard Urine Culture in Patients With Complicated or Persistently Recurrent Urinary Tract Infections. JU Open Plus. 1(5). 11 indexed citations

Niecko, Timothy, et al.. (2021). Reduced Hospitalizations and Amputations in Patients with Diabetic Foot Ulcers Treated with Cyclical Pressurized Topical Wound Oxygen Therapy: Real-World Outcomes. Advances in Wound Care. 11(12). 657–665. 11 indexed citations

Niecko, Timothy, et al.. (2021). Reduced Hospitalizations and Amputations in Patients with Diabetic Foot Ulcers Treated with Cyclical Pressurized Topical Wound Oxygen Therapy: Real World Outcomes. SSRN Electronic Journal. 1 indexed citations

O’Donnell, Thomas F., et al.. (2020). Correlation of disease comorbidity with prescribed treatment among insured U.S. lymphedema patients. Journal of Vascular Surgery Venous and Lymphatic Disorders. 9(2). 461–470. 3 indexed citations

O’Donnell, Thomas F., et al.. (2019). Lymphedema-associated comorbidities and treatment gap. Journal of Vascular Surgery Venous and Lymphatic Disorders. 7(5). 724–730. 32 indexed citations

Rockson, Stanley G., et al.. (2018). Use of Advanced Pneumatic Compression Devices Confers a Cost-Effective Reduction of Medical Resource Utilization in Phlebolymphedema. Journal of Vascular Surgery Venous and Lymphatic Disorders. 6(2). 298–298. 1 indexed citations

Niecko, Timothy, et al.. (2018). Health and economic benefits of advanced pneumatic compression devices in patients with phlebolymphedema. Journal of Vascular Surgery. 69(2). 571–580. 18 indexed citations

Cohen, Adam J., et al.. (2018). US budget impact of increased payer adoption of the Flexitouch advanced pneumatic compression device in lymphedema patients with advanced chronic venous insufficiency and multiple infections. Journal of Medical Economics. 21(10). 993–1000. 3 indexed citations

Purdum, Anna, Timothy Niecko, & Yin Yang. (2018). Real world survival rates and healthcare utilization among SEER-Medicare patients treated with hematopoietic stem cell transplant (HSCT) for relapsed/refractory diffuse large b-cell lymphoma (RR-DLBCL).. Journal of Clinical Oncology. 36(15_suppl). e19502–e19502. 2 indexed citations

10.

Foley, John, Kavita Nair, Timothy R. Vollmer, et al.. (2017). Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis. Patient Preference and Adherence. Volume 11. 1035–1048. 19 indexed citations

11.

Shoffstall, Andrew J., Timothy Niecko, Diah Douglas, et al.. (2016). The High Direct Medical Costs of Prader-Willi Syndrome. The Journal of Pediatrics. 175. 137–143. 25 indexed citations

12.

Lacey, Loretto, Joel Bobula, Timothy Niecko, & Christopher Leibman. (2016). Informal Care Time and Cost in a Large Clinical Trial Sample of Patients with Mild to Moderate Alzheimer’s Disease: Determinants and Level of Change Observed. Neurology and Therapy. 6(1). 11–23. 7 indexed citations

13.

Nair, Kavita, John Foley, Judith Stephenson, et al.. (2015). Physical Aspects of Quality of Life (QoL) over 3 Years in Patients with Multiple Sclerosis (MS) Initiating Natalizumab Treatment Earlier Versus Later in the Course of Disease (P3.276). Neurology. 84(14_supplement). 1 indexed citations

14.

Kappos, Ludwig, Robert J. Fox, Ralf Gold, et al.. (2014). Effect of Delayed-Release Dimethyl Fumarate on Health-Related Quality of Life in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients According to Prior Therapy: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies (P3.162). Neurology. 82(10_supplement).

15.

Harrison, John, Dorene M. Rentz, Trent McLaughlin, et al.. (2014). Cognition in MCI and Alzheimer’s Disease: Baseline Data from a Longitudinal Study of the NTB. The Clinical Neuropsychologist. 28(2). 252–268. 10 indexed citations

16.

Lacey, Loretto, et al.. (2013). Association between illness progression measures and total cost in Alzheimer's disease. The journal of nutrition health & aging. 17(9). 745–750. 13 indexed citations

17.

Sands, Bruce E., Corey A. Siegel, William J. Sandborn, et al.. (2009). Natalizumab reduces the rate of hospitalization in moderate to severe Crohnʼs Patients: Evidence from the Clinical Trial Program. Inflammatory Bowel Diseases. 15. S27–S27. 1 indexed citations

18.

Buxton, Martin, Loretto Lacey, Brian G. Feagan, et al.. (2007). Mapping from Disease-Specific Measures to Utility: An Analysis of the Relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's Disease and Measures of Utility. Value in Health. 10(3). 214–220. 71 indexed citations

19.

Feagan, Brian G., William J. Sandborn, Steven Hass, Timothy Niecko, & Jeffrey D. White. (2007). Health-Related Quality of Life During Natalizumab Maintenance Therapy for Crohn's Disease. The American Journal of Gastroenterology. 102(12). 2737–2746. 38 indexed citations

20.

Reilly, Margaret C., Victoria Barghout, Christopher R. McBurney, & Timothy Niecko. (2005). Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation. Alimentary Pharmacology & Therapeutics. 22(5). 373–380. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact